Cherwell increases commitment to pharmaceutical microbiology in Republic of Ireland
Ritchie Mooney appointed as Sales Specialist, based in the Republic of Ireland.
Cherwell Laboratories, specialists in cleanroom microbiology solutions for the pharmaceutical and related industries, are continuing their drive to improve support for pharmaceutical microbiology in the Republic of Ireland. As part of this initiative, Cherwell has appointed Ritchie Mooney as Sales Specialist, based in the Republic of Ireland. To further establish their commitment to the Irish market, Cherwell will also be supporting and attending the Pharmig conference on the 18 May in Cork, Ireland.
Prior to joining Cherwell Laboratories, Ritchie has worked for both manufacturers and distributors in the Life Science and associated industries for almost 20 years. During his time with Veltek Associates in particular, Ritchie acquired a good knowledge of Environmental Monitoring sampling and equipment, along with fogging systems and sterile disposable products for cleaning and disinfection purposes. Commenting on his new position at Cherwell, Ritchie said: “I am excited to be joining Cherwell and I am really looking forward to helping customers in Ireland with our Redipor Prepared Media in relation to various applications, such as environmental monitoring, product sterility testing, operator validation and process validation, amongst others.”
Andrew Barrow, Sales Manager of Cherwell, commented: “With Cherwell now shipping Redipor product directly to customers in the Republic of Ireland, we welcome Ritchie to the team. His previous experience within the industry; good understanding and appreciation of GMP and sterile production; along with his knowledge of the latest industry guidelines; means that Ritchie is able to fully understand and help us satisfy customer needs.”
Ritchie Mooney and Andrew Barrow will both be representing Cherwell at the Pharmig conference held on the 18 May at Fota Island Hotel, Cork. They will be on hand to offer practical advice on Cherwell’s products and their applications within environmental monitoring, sterility testing of products, and process validation. The event will highlight Current Hot Topics in Pharmaceutical Microbiology. Topics covered include: data integrity and new expectations; EM incubation strategies; contamination control and regulatory requirements. Also, at the same venue, Pharmig is hosting a second event on 19 May Focusing on Control of Pharmaceutical Water Systems Topics will include, Annex 1 and ISO 14644 updates; data integrity and disinfectant efficacy testing.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance